Diaphragmatic Evaluation by Fluoroscopy to Identify Phrenic Nerve Dysfunction Related to Electroporation | MicrobiomeTrials← Back to trialsNCT07462910
Diaphragmatic Evaluation by Fluoroscopy to Identify Phrenic Nerve Dysfunction Related to Electroporation
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06-02Est. Completion: 2027-05-31
Enrollment target: 250 participants Locations- Montreal Heart Institute, Montreal, Canada
- CHRU de Tours - Hôpital Trousseau, Chambray-lès-Tours, France
- CHU de Lyon - Hôpital Croix-Rousse, Lyon, France
- Centre Hospitalier de Pau - Hôpital François Mitterrand, Pau, France
- CHU de Bordeaux - Hôpital Haut-Lévêque, Pessac, France
- Centre Cardiologique du Nord, Saint-Denis, France
- Institut Cardiovasculaire de Strasbourg - Clinique Rhéna, Strasbourg, France
- Clinique Pasteur, Toulouse, France
- Auckland City Hospital, Auckland, New Zealand
Other microbiome trials you might be interested in
Mitral Valve ProlapseMitral Regurgitation
Mitral regurgitation (MR) is the second most frequent valvular heart disease and the second most frequent indication for…
Milan, ItalyEst. completion Jun 1, 2029
Hypertrophic Cardiomyopathy (HCM)
Hypertrophic cardiomyopathy (HCM) is a genetically mediated myocardial disease predominantly caused by pathogenic mutati…
Xi'an, ChinaEst. completion Dec 31, 2030
Stroke
Transient Ischemic Attack
After a first stroke or transient ischemic attack (TIA), the risk of recurrence is high in the weeks and months followin…
Brest, FranceEst. completion Dec 2027